Nektar Therapeutics

NKTR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000906709

SEC filings (opens in a new tab)

In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 2 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Nektar Therapeutics changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of NKTR: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Of which not filed for Q3 2025	Q3 2025	Change
Holders	109	1	153	+45
Shares	7.65M	40	14.4M	+6.76M (+88.3%)
Value	$197.7M	$1.03K	$820.2M	+$622.5M (+314.9%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (65)

Institutions that held Nektar Therapeutics at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to NKTR in Q3 2025
Institution	Shares	Value	% of portfolio
BVF Inc	1,276,595	$72.6M	2.94%
Farallon Capital Management, L.L.C.	791,000	$45.0M	0.25%
Citadel Advisors LLC	361,073	$20.5M	0.02%
Emerald Advisers, LLC	323,246	$18.4M	0.59%
Jefferies Financial Group Inc.	303,200	$17.3M	0.16%
Great Point Partners LLC	300,000	$17.1M	7.13%
Emerald Mutual Fund Advisers Trust	233,205	$13.3M	0.69%
Two Sigma Advisers, LP	178,908	$10.2M	0.02%
Voloridge Investment Management, LLC	171,776	$9.77M	0.03%
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.	153,846	$8.75M	0.68%
Point72 Asset Management, L.P.	123,658	$7.04M	0.02%
Sofinnova Investments, Inc.	118,419	$6.74M	0.41%
Quinn Opportunity Partners LLC	109,868	$6.25M	0.46%
Hudson Bay Capital Management LP	107,678	$6.13M	0.04%
Trexquant Investment LP	91,480	$5.21M	0.05%
Deutsche Bank AG	90,000	$5.12M	0.00%
Diadema Partners LP	75,000	$4.27M	2.97%
Longaeva Partners L.P.	62,729	$3.57M	0.76%
Artia Global Partners LP	57,999	$3.30M	0.58%
StemPoint Capital LP	53,201	$3.03M	0.61%
F/M Investments LLC	53,088	$3.02M	0.12%
Superstring Capital Management LP	51,270	$2.92M	2.87%
Propel Bio Management, LLC	49,000	$2.79M	2.79%
Readystate Asset Management LP	45,042	$2.56M	0.12%
AWM Investment Company, Inc.	40,000	$2.28M	0.21%
Walleye Capital LLC	36,107	$2.05M	0.02%
Squarepoint Ops LLC	34,500	$1.96M	0.00%
Verition Fund Management LLC	24,415	$1.39M	0.01%
Engineers Gate Manager LP	17,630	$1.00M	0.01%
Erste Asset Management GmbH	17,000	$1.00M	0.01%
Persistent Asset Partners Ltd	17,270	$982.7K	0.71%
Susquehanna Portfolio Strategies, LLC	16,057	$913.6K	0.01%
Caxton Associates LLP	13,977	$795.3K	0.02%
SEI Investments Co	13,744	$782.0K	0.00%
HRT Financial LP	13,158	$748.0K	0.00%
Envestnet Asset Management Inc	10,086	$573.9K	0.00%
HB Wealth Management, LLC	9,244	$526.0K	0.00%
Glenmede Investment Management, LP	9,200	$523.5K	0.00%
Dark Forest Capital Management LP	9,185	$522.6K	0.02%
Kestra Advisory Services, LLC	7,650	$435.3K	0.00%
49 Wealth Management, LLC	5,981	$340.3K	0.03%
XTX Topco Ltd	5,897	$335.5K	0.02%
Tudor Investment Corp Et Al	5,435	$309.3K	0.00%
Rangeley Capital, LLC	4,895	$278.5K	0.26%
LPL Financial LLC	4,754	$270.5K	0.00%
Fifth Lane Capital, LP	4,500	$256.1K	0.26%
Bank of New York Mellon Corp	4,327	$246.2K	0.00%
Brevan Howard Capital Management LP	4,109	$233.8K	0.00%
Cubist Systematic Strategies, LLC	4,097	$233.1K	0.00%
Birchview Capital, LP	4,021	$228.8K	0.17%
Qube Research & Technologies Ltd	3,974	$226.1K	0.00%
Great Lakes Advisors, LLC	3,922	$223.2K	0.00%
JustInvest LLC	3,911	$222.5K	0.00%
Vontobel Holding Ltd.	1,900	$108.1K	0.00%
Bayforest Capital Ltd	1,679	$95.5K	0.05%
Rhumbline Advisers	100	$5.69K	0.00%
CIBC Private Wealth Group, LLC	100	$5.69K	0.00%
Quantbot Technologies LP	88	$5.01K	0.00%
MTM Investment Management, LLC	66	$3.75K	0.00%
Massmutual Trust Co FSB	64	$3.64K	0.00%
MAI Capital Management	33	$1.88K	0.00%
Fortitude Family Office, LLC	21	$1.20K	0.00%
Caitong International Asset Management Co., Ltd	11	$626	0.00%
SRS Capital Advisors, Inc.	9	$512	0.00%
Montag A & Associates Inc	7	$399	0.00%

Sold out (20)

Institutions that held Nektar Therapeutics at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of NKTR in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
AQR Capital Management LLC	427,867	$11.1M
TCG Crossover Management, LLC	266,666	$6.89M
Schonfeld Strategic Advisors LLC	101,505	$2.62M
CM Management, LLC	45,000	$1.16M
Monaco Asset Management SAM	43,966	$1.14M
Ieq Capital, LLC	38,255	$988.5K
Boothbay Fund Management, LLC	20,962	$541.7K
Dimensional Fund Advisors LP	14,380	$371.5K
Marshall Wace, LLP	14,200	$366.9K
Victory Capital Management Inc	14,137	$365.3K
Quantessence Capital LLC	8,645	$223.4K
Wealth Enhancement Advisory Services, LLC	8,489	$210.2K
Allostery Investments LP	4,000	$103.4K
Essential Partners LLC	3,732	$96.4K
Caption Management, LLC	2,776	$71.7K
Public Employees Retirement System of Ohio	2,429	$62.8K
Raymond James Financial Inc	313	$8.09K
True Wealth Design, LLC	106	$2.74K
United Community Bank	7	$181
Clearstead Advisors, LLC	5	$130

Not filed for Q3 2025 yet (1)

Institutions that held Nektar Therapeutics at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NKTR in Q2 2025 that haven't filed for Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Atlas Capital Advisors LLC	40	$1.03K